Financial Information

Consolidated Balance Sheet

Assets(¥ million)
119th period 120th period
Month of Settlement March 2023 March 2024
Current Assets 39,273 38,639
Fixed Assets 29,849 29,400
Breakdown Tangible fixed Assets 23,467 22,838
Intangible fixed assets 1,233 985
Investment and other assets 5,148 5,576
Total Assets 69,123 68,039
Liabilities(¥ million)
119th period 120th period
Month of settlement March 2023 March 2024
Current liabilities 19,178 16,880
Fixed Liabilities 9,341 9,455
Total liabilities 28,519 26,336
Net Assets(¥ million)
119th period 120th period
Settlement Date March 2023 March 2024
Stockholders' Equity 39,562 40,219
Breakdown Capital 5,451 5,451
Capital Surplus 4,186 4,186
Retained Earnings 30,127 31,233
Treasury Stock △203 △652
Accumulated Other Comprehensive Income 1,041 1,484
Breakdown Valuation Difference on Other Securities 223 362
Foreign Currency Translation Adjustment Account 10 81
Accumulated Adjustment for Retirement Benefits 807 1,040
Total Net Assets 40,603 41,703
Total Liabilities and Net Assets 69,123 68,039

Consolidated Statement of Income

(¥ million)
119th period 120th period
Month of settlement March 2023 March 2024
Net sales 45,560 46,859
Cost of sales 32,586 32,988
Gross profit 12,974 13,871
Selling, general and administrative expenses 11,365 11,798
Other income 284 303
Other expenses 145 175
Ordinary income 1,748 2,201
Extraordinary income 1,683 71
Extraordinary loss - -
Income before income taxes 3,431 2,273
Corporate tax, etc 1,059 445
Net income 2,371 1,827
Net income attributable to non-controlling shareholders - -
Net income attributable to owners of parent 2,371 1,827

Consolidated Cash Flow

(¥ million)
119th period 120th period
Month of settlement March 2023 March 2024
Cash flows from operating activities 2,917 3,187
Cash flows from investing activities △1,153 △3,692
Cash flows from financing activities △867 △1,225
Exchange differences on cash and cash equivalents 11 27
Change in cash and cash equivalents 908 1,702
Cash and cash equivalents at beginning of year 13,844 14,752
Cash and cash equivalents at end of year 14,752 13,049

Capital Investment and Depreciation

Share this page

IR Support